Wolverine Asset Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Wolverine Asset Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-408,646	Closed	-$6.93M	–	2477
2014 Q4	$6.93M	Buy	+408,646	New	+$5.75M	0.13%	136

Wolverine Asset Management's AVNR Position: Q1 2015 in Review

Wolverine Asset Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 408,646 shares — an estimated $6.93M sold.

Wolverine Asset Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $6.93M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Wolverine Asset Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Wolverine Asset Management sold 408,646 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $6.93M.
Wolverine Asset Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Wolverine Asset Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $6.93M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Wolverine Asset Management's 13F filing for Q1 2015, filed 15 May 2015.